How does psoriasis affect quality of life? Assessing an Ingram-regimen outpatient programme and validating the WHOQOL-100

The British Journal of Dermatology
S M SkevingtonC R Lovell

Abstract

BACKGROUND, OBJECTIVES AND METHODS: This paper reports a longitudinal study of the quality of life (QOL) of outpatients receiving treatment for psoriasis in secondary care that was designed to validate a new QOL measure for use in psoriasis: the WHOQOL-100. Additional aims were to monitor the changes to the QOL of psoriasis patients (n = 83) following a course of topical treatment--a modified Ingram regimen--and to compare their QOL with healthy people (n = 105). General QOL was much improved following treatment; psychological facets of body image and appearance, self-esteem and negative feelings were particularly responsive to clinical change, in addition to positive feelings and cognitive capacity. Domains on spirituality, independence and physical health also improved. Compared with healthy controls, pretreatment psoriasis patients showed poorer physical, psychological, independence and spiritual QOL. Validity and reliability were investigated and found to be good to excellent. Internal consistency was very good in 23 facets out of 25. Domains and facets were strongly correlated (weaker for spirituality) largely reaffirming the WHOQOL concept. While physical, independence and psychological domains have some components simila...Continue Reading

References

Sep 1, 1976·Clinical and Experimental Dermatology·R G Jobling
Dec 1, 1990·The British Journal of Dermatology·A Y FinlayM S Salek
Nov 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·S C Wessely, G H Lewis
Jan 1, 1989·Journal of the American Academy of Dermatology·I H Ginsburg, B G Link
Feb 1, 1988·The British Journal of Dermatology·B Ramsay, M O'Reagan
Oct 1, 1995·The British Journal of Dermatology·H A Kurwa, A Y Finlay
Feb 1, 1995·International Journal of Dermatology·R G FriedA Shalita
Feb 1, 1995·The British Journal of Dermatology·A Y Finlay, E C Coles
May 1, 1994·Clinical and Experimental Dermatology·A Y Finlay, G K Khan
Apr 1, 1993·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
Mar 13, 1999·Social Science & Medicine·S M SkevingtonS Saxena
Jan 7, 2000·Journal of Psychosomatic Research·S M Skevington
Mar 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·S M Skevington, A Wright
May 23, 2002·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Suzanne M Skevington
May 29, 2003·Dermatology : International Journal for Clinical and Investigative Dermatology·A Y FinlayUNKNOWN Alefacept Clinical Study Group
Apr 3, 2004·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M S SalekM I Sumner
Apr 17, 2004·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·S M SkevingtonUNKNOWN WHOQOL Group
Apr 17, 2004·The Journal of Investigative Dermatology·Francesca SampognaUNKNOWN IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Investigators
Jun 18, 2004·Current Opinion in Rheumatology·William J Taylor
Jun 19, 2004·Acta Dermato-venereologica·Robert ZachariaeHans Christian Wulf
Sep 16, 2004·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Stephen P McKennaRudolph Erdman
Sep 29, 2004·Dermatologic Clinics·Rita MukhtarJohn Y M Koo
Nov 4, 2004·Journal of the American Academy of Dermatology·Joel M GelfandDavid J Margolis
Dec 21, 2004·The British Journal of Dermatology·H L RichardsC E M Griffiths

❮ Previous
Next ❯

Citations

Aug 8, 2009·American Journal of Clinical Dermatology·Dennis LinderGiampiero Girolomoni
Dec 25, 2010·Indian Journal of Psychiatry·K H BasavarajR Rashmi
Dec 3, 2014·The Psychiatric Clinics of North America·Edgardo Rodriguez-Vallecillo, Michel A Woodbury-Fariña
Jul 6, 2013·Actas dermo-sifiliográficas·E DaudénUNKNOWN VACAP Study Investigators
Jan 31, 2012·Dermatologic Clinics·Seema P Kini, Laura K DeLong
Nov 9, 2007·The Journal of Investigative Dermatology·Hilde BothTamar Nijsten
Aug 30, 2008·Clinics in Dermatology·Marc Alexander Radtke, Matthias Augustin
Jan 29, 2008·Journal of Psychosomatic Research·Brett D ThombsJames A Fauerbach
Jun 28, 2011·International Journal of Dermatology·Kabbur H BasavarajRamesh Rashmi
Dec 9, 2010·The British Journal of Dermatology·E J McGrathS M Skevington
Feb 2, 2011·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Suzanne M Skevington, Farah M McCrate
Aug 3, 2007·The Journal of Dermatological Treatment·Lena RingJörgen Serup

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.